Has Khaled Mahlies, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,092 in general payments to Khaled Mahlies, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khaled Mahlies, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khaled Mahlies, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khaled Mahlies, MD

Internal Medicine · Bedford, OHNPI 1497720585

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,319 and has fallen 76.6% since, to $309 in 2025.

$4,092in general payments, 2019–2025

Across 65 payments — averaging $62.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$900
AstraZeneca$620
Boehringer Ingelheim$552
Organogenesis Inc.$542
Esperion Therapeutics, Inc.$374
Olympus America Inc.$309
plus $796 from 10 others

What the payments were for

Food & beverage$4,087100%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	16	$900
AstraZeneca	6	$620
Boehringer Ingelheim	5	$552
Organogenesis Inc.	6	$542
Esperion Therapeutics, Inc.	5	$374
Olympus America Inc.	2	$309
Novartis	7	$194
KCI USA, Inc.	3	$192
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$133
AbbVie	5	$74
Boston Scientific	1	$70
Misonix Inc	2	$48
Tetraphase Pharmaceuticals, Inc.	1	$48
Paratek Pharmaceuticals, Inc.	1	$13
Abbott	1	$12
Nestle Healthcare Nutrition Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,092 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$21,670

Medicare patients

Services billed

211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	54	$780
Albuterol Sulfate HfaAlbuterol Sulfate	34	$740
Amlodipine Besylate	92	$465
Gabapentin	27	$391
Omeprazole	18	$378
Risperidone	16	$354
Atorvastatin Calcium	53	$325
Tamsulosin Hcl	14	$302
Rosuvastatin Calcium	23	$283
Lisinopril	50	$276
Potassium Chloride	13	$271
Dorzolamide Hcl	13	$269
Metoprolol Tartrate	29	$232
Simvastatin	19	$211
Montelukast Sodium	29	$196

Paid to pharmacies, not to this prescriber.

Other internal medicine in Bedford

Hassan MalikAkron$1.7M
Cyrus HarrisCleveland$726K
Nina DeepWesterville$614K
Necklall KhooblallAustintown$448K
Daniel WeissMentor$406K
Richard KimDayton$326K
Marina MagreyCleveland$312K
Lisa LarkinCincinnati$276K
Gregg FaimanMayfield Hts$274K
Vincent MartinCincinnati$261K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →